COVID-19 and diabetes mellitus
FA Jungheim - 2023 - zir.nsk.hr
Sažetak The incidence of COVID-19 in DM2 ranged from 10.8-22%. Due to a constant
chronic inflammation, as is seen in DM2 patients, they present with increased susceptibility …
chronic inflammation, as is seen in DM2 patients, they present with increased susceptibility …
Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States
Background We aimed to clarify the relationship between coronavirus disease 2019 (COVID-
19) reinfection and basic disease and smoking status. Methods The electronic health …
19) reinfection and basic disease and smoking status. Methods The electronic health …
Therapy of Type 2 Diabetes
R Landgraf, J Aberle, AL Birkenfeld… - Experimental and …, 2024 - thieme-connect.com
Change 2: On the basis of current data, the various risk factors and their structured
assessment (including the increasing importance of fatty liver) for the development of …
assessment (including the increasing importance of fatty liver) for the development of …
[PDF][PDF] Risk Factors Leading To the Severe Exacerbation of COVID-19 Include Male, Elderly, Obesity and Diabetes
B Hab - Diabetes, 2021 - repo.lib.tokushima-u.ac.jp
The risk factors for coronavirus disease (COVID-19) were investigated. Latest cohort study
for 28,095 cases was conducted in United States. It included obesity 61.9% and type 2 …
for 28,095 cases was conducted in United States. It included obesity 61.9% and type 2 …
Rapamycin and metformin in treating COVID-19
A Karp - The Science Journal of the Lander College of Arts …, 2021 - touroscholar.touro.edu
The SARS-CoV-2 virus has spread rapidly, resulting in a global pandemic. There is a great
need for an effective drug cocktail therapy to combat Acute Respiratory Distress Syndrome …
need for an effective drug cocktail therapy to combat Acute Respiratory Distress Syndrome …
Management von Diabetespatienten in der COVID-19-Pandemie
C Steenblock, C Hoffmann, TD Rachner… - Diabetes …, 2022 - thieme-connect.com
Über 10% der deutschen Bevölkerung leiden an metabolischen Krankheiten wie Diabetes,
Adipositas, oder nicht alkoholischer Steatohepatitis. Betroffene sind während der COVID-19 …
Adipositas, oder nicht alkoholischer Steatohepatitis. Betroffene sind während der COVID-19 …
COVID-endocrinologia: il caso della tiroide, del diabete e dell'ipovitaminosi D
S Antonini, MF Birtolo, G Maida, M Mirani, G Mazziotti… - L'endocrinologo, 2021 - Springer
L'infezione da SARS-CoV-2 è rapidamente diventata una pandemia globale, con più di 100
milioni di persone infettate e 2, 3 milioni di morti nel mondo. Particolare attenzione è stata …
milioni di persone infettate e 2, 3 milioni di morti nel mondo. Particolare attenzione è stata …
[PDF][PDF] Antidiabetic drugs in patients with Covid-19 infection
K Theocharis, C Antza, G Kostopoulos, V Kotsis - researchgate.net
The COVID-19 pandemic has posed new challenges to the management of the ever-
growing group of patients with Diabetes Mellitus (DM). An important question to be …
growing group of patients with Diabetes Mellitus (DM). An important question to be …
[PDF][PDF] Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
W Jingya, JM Cooper, R Surenthirakumaran - 2021 - 192.248.56.27
Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
Page 1 The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 5, 1255–1268 …
Page 1 The Journal of Clinical Endocrinology & Metabolism, 2021, Vol. 106, No. 5, 1255–1268 …
[PDF][PDF] CONTROVERSIE IN DIABETOLOGIA: METFORMINA, 50 ANNI E NON SENTIRLI
G Sesti - ildiabeteonline.it
Sixty years after its introduction in the therapeutic arsenal of type 2 diabetes, metformin
remains the first-line treatment of type 2 diabetes according to national and international …
remains the first-line treatment of type 2 diabetes according to national and international …